Cost-effectiveness of Fracture Prevention in Established Osteoporosis
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 25 (sup103) , 30-38
- https://doi.org/10.3109/03009749609103742
Abstract
This study presents the results of a computer simulation model for calculating the cost-effectiveness and cost-utility of treating patients with established osteoporosis in order to reduce the risk of fractures. The results are based on Swedish data for risk of fracture and costs. The treatment intervention modelled is based on treatment of a 62-year-old woman with established osteoporosis. The cost per hip fracture avoided is 350,000 SEK, assuming a 50% reduction in the risk of fracture due to 5 years of treatment. A sensitivity analysis for changes in the cost and effectiveness of treatment, the risk of fracture and the discount rate is performed. The cost per life-year gained and the cost per quality-adjusted life-year (QALY) gained is presented to enable comparison of the cost-effectiveness of treating osteoporosis with that of other health care interventions. A comparison between treating the same woman for osteoporosis and mild hypertension shows a cost per life-year gained of 220,000 SEK and 128,000 SEK respectively. Cost per QALY gained is very similar for the two interventions: 105,000 SEK and 103,000 SEK respectively. This model provides a tool to enable clinicians, administrators and health policy makers to analyze and understand the economic aspects of a major health policy issue.Keywords
This publication has 10 references indexed in Scilit:
- Mortality and morbidity after hip fractures.BMJ, 1993
- Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosisThe American Journal of Medicine, 1993
- Predicting various fragility fractures in women by forearm bone densitometry: A follow-up studyCalcified Tissue International, 1993
- Consequences of a hip fracture: A prospective study over 1 yearOsteoporosis International, 1993
- Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.BMJ, 1992
- Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.BMJ, 1992
- Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P componentThe Lancet, 1991
- Costs of hip fracture: Rehabilitation of 180 patients in primary health careActa Orthopaedica, 1991
- The Costs of Treating Hypertension in SwedenScandinavian Journal of Primary Health Care, 1991
- Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are consideredThe American Journal of Medicine, 1986